Samsung partners with a clinical research firm and will provide health data from its wearable devices
Samsung Teams Up with Alcedis to Transform Wearable Data into Clinical Insights
Samsung is taking a major step toward bridging the gap between everyday fitness tracking and professional medicine. By partnering with Alcedis, a leader in digital-first clinical research, the tech giant aims to turn the stream of metrics from Galaxy wearables into high-level, clinically validated data.
While millions of us already wear devices that monitor our heart rates and sleep patterns, turning that raw information into medical-grade evidence has historically been a challenge. That is where Alcedis steps in. They bring the expertise needed to process and translate biometric data, ensuring it meets the rigorous standards required for pharmaceutical development and medical research.
Why This Matters for Health Tech
Wearables offer an incredibly cost-effective way to gather continuous, real-world health data without the need for constant clinic visits. With this partnership, Samsung and Alcedis are focusing on specific, high-value metrics, including:
- Bioelectrical Impedance Analysis (BIA): For precise body composition tracking.
- Electrodermal Activity (EDA): A key indicator for stress and nervous system response.
- Advanced Cardiac & Respiratory Monitoring: Including detection for Atrial Fibrillation (AFib) and signs of obstructive sleep apnea (OSA).
By leveraging Samsung’s massive reach with its Galaxy Watch lineup, this collaboration could set a new standard for how we use personal tech to catch health issues before they become emergencies. It is a smart move that moves wearable tech beyond simple step counting and firmly into the world of proactive healthcare.
